Ledger.Open graph →

SEC Form D · filed January 30, 2020

IMPEL NEUROPHARMA INC

Offering

$481K

Sold

—

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (36)

Diane D. Wilfong · Seattle, WADirector Mahendra D. Shah · Seattle, WADirector Aaron D. Royston · Seattle, WADirector Jon D. Congleton · Seattle, WAExec · Director John D. Hoekman · Seattle, WAExec · Director David D. Allison · Seattle, WADirector Stewart D. Parker · Seattle, WADirector Tim D. Nelson · Seattle, WADirector Adrian D. Adams · Seattle, WADirector Robert D. Mittendorff · Seattle, WADirector Ali D. Satvat · Seattle, WADirector John D. Leaman · Seattle, WAExec Anthony B. Davis · Chicago, ILDirector Andrew Parker · Chicago, ILDirector Thomas Ritter · Chicago, ILDirector Reed Sturtevant · Sunnyvale, CADirector Jocelyn White · London, United KingdomDirector Jack Oslan · Pleasanton, CADirector Terrence Schmid · SAN FRANCISCO, CAExec · Director Alexis Bjorlin · Sunnyvale, CAExec Michael Ettling · Miami, FLDirector David Lazovsky · Sunnyvale, CADirector Brian B. Miller · Chicago, ILDirector William Toms · SAN FRANCISCO, CAExec · Director Raphael Schorr · Boston, MADirector Michael Coe · Perry, KSDirector Jay Po · LINCOLN, MADirector Karim Faris · Boston, MADirector Megan A. Bailey · Baltimore, MDDirector Stephan Cubba · Detroit, MIExec · Director Ping Wang · MOUNTAIN VIEW, CADirector Yanjuan Chen · MOUNTAIN VIEW, CAExec · Director Rick Mcdonald · Miami Lakes, FLDirector Glen Littlejohn · Miami Lakes, FLDirector Brian Fitzpatrick · Miami Lakes, FLExec Johnson Agogbua · Reston, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗